IKZF1 deletion [46] and biallelic loss of CDKN2A [47] are poor prognostic factors in ALL and are more frequently observed in refractory ALL patients than in newly diagnosed ALL cases [48]. This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.